Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma. [electronic resource]
Producer: 20030612Description: 1348-9 p. digitalISSN:- 0140-6736
- Angiomyolipoma -- genetics
- Animals
- Antibiotics, Antineoplastic -- pharmacology
- Cell Division -- drug effects
- Germ-Line Mutation -- genetics
- Humans
- Immunoenzyme Techniques
- Kidney -- pathology
- Kidney Neoplasms -- genetics
- Mice
- Phosphorylation -- drug effects
- Protein Kinase Inhibitors
- Protein Kinases -- genetics
- Proteins -- genetics
- Repressor Proteins -- genetics
- Ribosomal Protein S6 Kinases, 70-kDa -- genetics
- Signal Transduction -- drug effects
- Sirolimus -- pharmacology
- TOR Serine-Threonine Kinases
- Tuberous Sclerosis -- genetics
- Tuberous Sclerosis Complex 1 Protein
- Tuberous Sclerosis Complex 2 Protein
- Tumor Suppressor Proteins
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.